Carnegie acted as adviser to IDI in the divestment of Pharmadule Emtunga, a world leading manufacturer of high technology facilities to primarily the pharmaceutical, biotech and offshore industries. IDI is an independent private equity company focusing on small to middle-sized companies in northern Europe. 3i invests in businesses across three continents through local investment teams in Europe, Asia Pacific and the USA. February, 2004.
Healthcare
Divestment of Pharmadule Emtunga (SE) to 3i (UK) by Industrial Development & Investment AB (“IDI”) (SE) — Amount not disclosed.
February 2004